SIDE EFFECTS: The most common side effects of erlotinib are:
- loss of appetite,
- weight loss,
- stomach pain,
- shortness of breath,
- mouth sores,
- dry skin,
- itching, and
Any of these can occur in about half of all patients who receive the medicine, but these effects are usually mild. There have been rare reports of serious lung disease, including deaths, in patients receiving erlotinib for treatment of NSCLC or other tumors.
Other important side effects include:
- Liver failure,
- kidney failure,
- increased bleeding rates,
- gastrointestinal perforation, and
- corneal perforation or ulceration.
PREPARATIONS: Tablets: 25, 100, and 150 mg
STORAGE: Erlotinib should be stored at room temperature, 15 C - 30 C (59 F - 86 F).
DOSING: The usual dose of erlotinib is 150 mg daily for NSCLC and 100 mg daily for pancreatic cancer. Erlotinib should be taken on an empty stomach at least one hour before or two hours after eating because food may reduce the absorption of erlotinib.
Quick GuidePancreatic Cancer Symptoms, Causes, and Treatment
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Use the pill identifier tool on RxList.